Novo Nordisk xStock is projected to rise to $67.69 by 2027, a +50% move from its current price of $45.05. NVOX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy. Market sentiment sits at 22/100 (Extreme Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 5/26/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $44.34 | $45.11 | $45.90 | +0.13% |
| May 30 | $44.08 | $45.17 | $46.29 | +0.26% |
| May 31 | $43.90 | $45.23 | $46.60 | +0.40% |
| Jun 1 | $43.75 | $45.29 | $46.88 | +0.53% |
| Jun 2 | $43.63 | $45.35 | $47.13 | +0.66% |
| Jun 3 | $43.53 | $45.41 | $47.37 | +0.80% |
| Jun 4 | $43.44 | $45.47 | $47.59 | +0.93% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $43.44 | $45.47 | $47.59 | +0.93% |
| Week 2 | $43.02 | $45.89 | $48.95 | +1.86% |
| Week 3 | $42.79 | $46.32 | $50.13 | +2.81% |
| Week 4 | $42.67 | $46.75 | $51.22 | +3.76% |
| Week 5 | $42.60 | $47.18 | $52.25 | +4.73% |
| Week 6 | $42.58 | $47.62 | $53.25 | +5.70% |
| Week 7 | $42.59 | $48.06 | $54.23 | +6.68% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Novo Nordisk xStock (NVOX) is a tokenized stock designed to give investors exposure to the value of Novo Nordisk through a digital token. xStocks are tokenized assets that are backed 1:1 by the underlying assets and carry a legal claim to the value of the stock. They are composable with DeFi protocols and are compliant with EU regulations, accessible to non-US users, and can be integrated with other DeFi protocols like any other token.
xStocks enable easy access to 57 US Stocks and ETFs to regular users through top centralized and decentralized exchanges. This structure allows investors to hold a token that represents real-world stock exposure while engaging with DeFi ecosystems and cross-chain capabilities.
The Novo Nordisk xStock symbolizes a broader category of tokenized stock assets that combines traditional equity exposure with the flexibility of digital asset rails.
Novo Nordisk xStock, ticker NVOX, currently trades at $45.05 and sits in the 3449th rank with a market capitalization of $660.44K. The asset has an all-time high of $66.15 and an all-time low of $34.26, reflecting a historically wide trading range.
The current price backdrop is supported by a forecast that envisions meaningful upside over the coming years. The average price projections rise from $45.05 in 2026 to a multi-thousand-dollar level by 2050, with substantial ROI tallies along the way (e.g., 50.3% in 2027 and 3243.6% by 2050), signaling a strong long-term bullish trajectory.
Key near-term levels include a support zone at $40.33 and a resistance at $47.19, with the 30-day price range between $40.99 and $49.52. The current price and forecast together illustrate a clear path of potential appreciation balanced by the usual market uncertainties.
A major floor 21.2% below — a decisive break under it would weaken the trend.
The nearest floor, 10.5% below — buyers have tended to step in here.
The nearest ceiling, 4.8% above — a clean break opens room to run.
A major ceiling 13.3% above — clearing it would confirm fresh momentum.
Key NVOX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NVOX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $44.93 | Buy | $44.97 | Buy |
| MA 10 | $44.67 | Buy | $44.94 | Buy |
| MA 20 | $45.37 | Sell | $44.65 | Buy |
| MA 50 | $42.40 | Buy | $43.23 | Buy |
| MA 100 | $40.82 | Buy | $43.37 | Buy |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.83 | Neutral |
| Stoch RSI (14) | 27.06 | Neutral |
| CCI (20) | -24.57 | Neutral |
| Williams %R (14) | -60.22 | Info |
| MACD (12,26,9) | -0.24 | Sell |
| ROC (12) | -4.43 | Sell |
| Bollinger %B (20,2) | 0.42 | Neutral |
| Stochastic %K (14) | 39.78 | Neutral |
| TRIX (15) | 0.30 | Buy |
| Awesome (5,34) | 0.95 | Buy |
| Ultimate (7,14,28) | 59.13 | Neutral |
| Momentum (10) | 1.38 | Buy |
| Aroon Osc (25) | 44.00 | Buy |
| Hull MA (9) | 45.17 | Sell |
| ADX (14) | 23.25 | Buy |
| ATR (14) | 0.44 | Info |
The 30-day technical picture shows bullish sentiment with RSI(14) at 60 and the 50-day simple moving average at $42.40. This setup suggests the stock may continue to test intraday dynamics toward the near-term resistance.
Over the next 30 days, traders will be watching the support at $40.33 and resistance at $47.19, with the current 30-day range spanning $40.99 to $49.52. The asset exhibits about 30% annualized volatility, underscoring the potential for swift moves within the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $35.48 | $45.05 | $49.30 | 0% | Neutral | |
| $53.52 | $67.69 | $90.80 | +50% | Bullish | |
| $94.96 | $123.52 | $171.86 | +174% | Bullish | |
| $97.78 | $130.21 | $186.48 | +189% | Bullish | |
| $89.72 | $122.00 | $179.05 | +171% | Bullish | |
| $140.31 | $194.46 | $291.57 | +332% | Bullish | |
| $233.27 | $329.11 | $503.04 | +631% | Bullish | |
| $198.36 | $284.58 | $442.63 | +532% | Bullish | |
| $189.11 | $275.66 | $435.70 | +512% | Bullish | |
| $316.50 | $468.46 | $751.55 | +940% | Bullish | |
| $721.38 | $1,144.56 | $1,954.86 | +24.4x | Bullish | |
| $841.76 | $1,506.27 | $2,818.56 | +32.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $35.48 | $45.05 | $52.82 | +0.00% |
| June 2026 | $39.85 | $46.87 | $56.47 | +4.03% |
| July 2026 | $42.84 | $50.81 | $62.06 | +8.42% |
| August 2026 | $40.09 | $47.86 | $59.07 | -5.81% |
| September 2026 | $35.81 | $42.99 | $53.52 | -10.17% |
| October 2026 | $36.33 | $43.85 | $55.01 | +1.98% |
| November 2026 | $36.22 | $43.91 | $55.46 | +0.15% |
| December 2026 | $31.85 | $38.78 | $49.30 | -11.69% |
Click any year to see its month-by-month NVOX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, NVOX could reach as high as $49.30, with a base case around $45.05 and support toward $35.48 — roughly 0% from $45.05. Price action looks broadly range-bound.
Expect NVOX to range from $53.52 to $90.80 through 2027. The $67.69 average target implies a +50% move from current prices. That is up +50% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The NVOX price prediction for 2028 points to an average of $123.52 (low $94.96, high $171.86) — a potential gain of +174% on today's $45.05. Momentum favours further upside here.
In 2029, NVOX is projected to trade between $97.78 and $186.48, averaging $130.21 — a potential gain of +189% from today's $45.05. That is up +5% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Novo Nordisk xStock's 2030 outlook centres on $122.00, within a $89.72 to $179.05 range. That is -6% versus the projected 2029 average. That marks a +171% change versus current levels. Momentum favours further upside here.
By 2031, NVOX could reach as high as $291.57, with a base case around $194.46 and support toward $140.31 — roughly +332% from $45.05. Buyers look set to stay in control over this stretch.
Expect NVOX to range from $233.27 to $503.04 through 2032. The $329.11 average target implies a +631% move from current prices. That is up +69% on the projected 2031 average. Momentum favours further upside here.
The NVOX price prediction for 2033 points to an average of $284.58 (low $198.36, high $442.63) — a potential gain of +532% on today's $45.05. Buyers look set to stay in control over this stretch.
In 2034, NVOX is projected to trade between $189.11 and $435.70, averaging $275.66 — a potential gain of +512% from today's $45.05. That is -3% versus the projected 2033 average. Momentum favours further upside here.
Novo Nordisk xStock's 2035 outlook centres on $468.46, within a $316.50 to $751.55 range. That is up +70% on the projected 2034 average. That marks a +940% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, NVOX could reach as high as $1,954.86, with a base case around $1,144.56 and support toward $721.38 — roughly +24.4x from $45.05. Momentum favours further upside here.
Expect NVOX to range from $841.76 to $2,818.56 through 2050. The $1,506.27 average target implies a +32.4x move from current prices. That is up +32% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in NVOX today (≈ 22.197558 NVOX) could be worth
$33,435.46
+$32,435.46 (+3244%) by 2050 · US Dollar
Based on the average projected NVOX price of $1,506.27 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NVOXwould be worth at today's price.
$1,000 invested in NVOX on Nov 20, 2025 (≈ 20.529665 NVOX) would be worth
$924.86
-$75.14 (-7.5%) today · 0.92× · US Dollar
Based on a NVOX entry price of $48.71 vs. today's $45.05.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $44.33 | $1,016.21 | +1.6% |
| 1 month ago | $41.21 | $1,093.26 | +9.3% |
| 3 months ago | $38.57 | $1,167.92 | +16.8% |
| 6 months ago | $48.86 | $922.02 | -7.8% |
| All time ago | $48.71 | $924.86 | -7.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NVOX forecast.
Our base-case forecast reaches $90.00 around 2028.
Implied market cap at $90.00: $1.32M
The multi-year forecast depicts substantial upside, with the avg price progressing from $45.05 in 2026 to $122.00 in 2030 and beyond. Notably, the forecast shows continued expansion through 2032 ($329.11), 2035 ($468.46), 2040 ($1,144.56), and 2050 ($1,506.27), indicating a long-run growth trajectory.
ROI figures illustrate accelerating gains: 0% in 2026, then 50.3% in 2027, 174.2% in 2028, 189% in 2029, 170.8% in 2030, 331.6% in 2031, 630.5% in 2032, 531.7% in 2033, 511.9% in 2034, 939.9% in 2035, 2440.6% in 2040, and 3243.6% in 2050. Sentiment shifts from Neutral in 2026 to Bullish from 2027 onward, underscoring an increasingly optimistic longer-term outlook.
These figures are estimates, not guarantees, and actual results may differ due to market conditions and other factors.
Tap a question to reveal the answer.
In 2030 the forecasted avg price is $122.00 with a min of $89.72 and a max of $179.05, and the ROI is 170.8%.
The forecast shows a bullish trajectory from 2027 onward with rising avg prices (e.g., $67.69 in 2027) and substantial ROI (e.g., 50.3% in 2027, up to 3243.6% by 2050). These are estimates and not guarantees.
Yes, the forecast shows an avg of $1,144.56 in 2040 and $1,506.27 in 2050, indicating values above $1,000 in the later years.
The current price is $45.05. The market capitalization is $660.44K, and the rank is 3449.
RSI(14) is 60 and the SMA50 is $42.40. The 30-day range is $40.99 to $49.52, with a support at $40.33 and a resistance at $47.19.
Novo Nordisk xStock Community Discussion
0Share your Novo Nordisk xStock price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.